Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.672
+0.030 (4.65%)
Mar 6, 2026, 4:00 PM EST - Market closed
Impact BioMedical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 0.03 | - | - | 0.05 | - | - | Upgrade
|
| Gross Profit | 0.02 | - | - | 0.05 | - | - | Upgrade
|
| Selling, General & Admin | 2.29 | 1.83 | 1.1 | 1.12 | 0.99 | 0.38 | Upgrade
|
| Research & Development | 0.12 | 0.28 | 1.69 | 1.23 | 1.08 | 0.51 | Upgrade
|
| Other Operating Expenses | 0.46 | 0.17 | 0.12 | - | - | - | Upgrade
|
| Operating Expenses | 4.01 | 3.4 | 4.03 | 3.45 | 3.19 | 0.9 | Upgrade
|
| Operating Income | -3.99 | -3.4 | -4.03 | -3.4 | -3.19 | -0.9 | Upgrade
|
| Interest Expense | -1.06 | -1.07 | -0.44 | -0.46 | -0.3 | - | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0.02 | 0.17 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -13.81 | 5.07 | 0.05 | 0.07 | 0.08 | - | Upgrade
|
| EBT Excluding Unusual Items | -18.85 | 0.62 | -4.41 | -3.78 | -3.24 | -0.9 | Upgrade
|
| Impairment of Goodwill | -25.09 | -25.09 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -4.1 | - | - | Upgrade
|
| Asset Writedown | -0.26 | -0.26 | - | - | - | - | Upgrade
|
| Pretax Income | -44.21 | -24.74 | -4.41 | -7.88 | -3.24 | -0.9 | Upgrade
|
| Income Tax Expense | 0.03 | 0.03 | - | -0.62 | -1.4 | -0.08 | Upgrade
|
| Earnings From Continuing Operations | -44.24 | -24.77 | -4.41 | -7.26 | -1.85 | -0.81 | Upgrade
|
| Minority Interest in Earnings | 0.05 | 0.06 | 0.07 | 0.2 | 0.55 | 0.22 | Upgrade
|
| Net Income | -44.19 | -24.71 | -4.34 | -7.05 | -1.3 | -0.6 | Upgrade
|
| Net Income to Common | -44.19 | -24.71 | -4.34 | -7.05 | -1.3 | -0.6 | Upgrade
|
| Shares Outstanding (Basic) | 12 | 11 | 60 | 70 | 70 | 70 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 11 | 60 | 70 | 70 | 70 | Upgrade
|
| Shares Change (YoY) | -80.23% | -82.14% | -14.54% | - | - | - | Upgrade
|
| EPS (Basic) | -3.69 | -2.30 | -0.07 | -0.10 | -0.02 | -0.01 | Upgrade
|
| EPS (Diluted) | -3.69 | -2.30 | -0.07 | -0.10 | -0.02 | -0.01 | Upgrade
|
| Free Cash Flow | -4.04 | -3.92 | -2.87 | -2.52 | -2.03 | -0.9 | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.36 | -0.05 | -0.04 | -0.03 | -0.01 | Upgrade
|
| Gross Margin | 92.00% | - | - | 100.00% | - | - | Upgrade
|
| Operating Margin | -15948.00% | - | - | -6808.00% | - | - | Upgrade
|
| Profit Margin | -176764.00% | - | - | -14102.00% | - | - | Upgrade
|
| Free Cash Flow Margin | -16160.00% | - | - | -5036.00% | - | - | Upgrade
|
| EBITDA | -3.13 | -3.39 | -4.02 | -2.29 | -2.07 | - | Upgrade
|
| D&A For EBITDA | 0.86 | 0.01 | 0.01 | 1.11 | 1.11 | - | Upgrade
|
| EBIT | -3.99 | -3.4 | -4.03 | -3.4 | -3.19 | -0.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.